Welcome to The StillCanna Report
We are excited to share our story with you as we embark on refining the future of CBD.
Former President of the College of Naturopathic Physicians of British Columbia Joins StillCanna's Team
VANCOUVER, May 16, 2019 /CNW/ - StillCanna Inc. (CSE: STIL) ("STIL" or the "Company") is pleased to announce that Dr. Brian Martin, ND has joined the StillCanna Team. Dr. Martin brings a wealth of knowledge and experience, including but not limited to:
- 25 years practicing Naturopathic Medicine;
- the formulation of innovative natural health products;
- former President of the College of Naturopathic Physicians of British Columbia; and
- Expert in Optimal Aging from the American Academy of Anti-Aging Medicine.
Dr. Martin will lead the Company's consumer and Nutraceutical and Cosmeceutical product formulations with the goal of enhancing the natural capabilities of CBD and other therapeutic cannabinoids, including terpenes and other organic compounds. He will be the Company's medical representative for industry research, speaking engagements and product formulations. Dr. Martin will evaluate the current Olimax product line and expects to formulate new CBD related products with a special focus on the expanding nutritional (food and beverages) and wellness marketplaces. Particular attention will be directed towards the female market, along with matters related to the improvement of quality of life, including products aiming to enhance energy, mood, memory, libido and athletic performance.
"Dr. Martin has dedicated his life to the proactive empowerment of the modern consumer, and has developed substantial practical experience and knowledge of the current health needs of both men and women," exclaimed Jason Dussault Chief Executive Officer of StillCanna. "We anticipate that his practical knowledge and capabilities will make StillCanna's CBD products increasingly effective and metabolically friendly compared to other products currently available in the market. Dr. Martin will work with the Company part time for the next 2 quarters with an eye towards full time employment as we expand our product vision."
"I have been very impressed with some of the proprietary techniques and technologies StillCanna has relating to the production and formulation of various CBD products," stated Dr. Martin. "StillCanna's vision of CBD in the wellness and the global Nutraceutical market is in line with the types of CBD products I envision. StillCanna's CEO has strong branding and marketing skills which, coupled with my formulation skills, paints a very exciting picture."
As partial compensation for the engagement of Dr. Martin, the Company will grant 200,000 incentive stock options to Dr. Martin with an exercise price equivalent to a 5% premium to the closing price of the Company's common shares on the date of grant.
Further to its press release dated May 7, 2019, the Company has also issued 850,000 common shares to certain finders in connection with the acquisition of Olimax. As a result, an aggregate of 1,300,000 common shares have been issued to finders in connection with the acquisition of Olimax.
For further information please contact:
Jason Dussault, CEO, Director EVI Global Group Developments Corp. E-mail: firstname.lastname@example.org
Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including the expected capacity of the facility to process 1,000,000 pounds of hemp annually, the facility’s expected capacity to process 3,000 pounds of flower daily, the company will likely have an advantage in 2019 and beyond and that the facility is expected to continue to process its hemp inventory in anticipation of extraction are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including that the facility will have the capacity to process 1,000,000 pounds of hemp annually, the facility will have the capacity to process 3,000 pounds of flower daily, the Company will have an advantage in 2019 and beyond and that the facility will continue to process its hemp inventory in anticipation of extraction. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, that the facility will not function as expected by management of the Company and will not have the capacity to process 1,000,000 pounds of hemp annually, the facility will not function as expected by management of the Company and will not have the capacity to process 3,000 pounds of flower daily, the Company will not have an advantage in 2019 and beyond and that the facility will not continue to process its hemp inventory in anticipation of extraction. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.
Neither the Canadian Securities Exchange (CSE or CNSX Markets Inc), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
As of November 16, 2018
We have filed our listing statement in connection with EVI Global Group Developments Corp.’s change of business with the CSE for comments.
Refinery #1 - Romania
July 1, 2018
COMPETED FACILITY ENGINEERING DRAWINGS
August 1, 2018
ORDERED CUSTOM MANUFACTURED EQUIPMENT AND SCIENTIFIC EQUIPMENT
September 1, 2018
HIRED LOCAL ARCHITECT FOR PERMITTING
November 15, 2018
ROMANIAN SUBSIDIARY COMPANY DOCUMENTS APPROVED & REGISTERED
November 22, 2018
ROMANIAN STAFFING PROCESS STARTED - FACILITY GM HIRED
November 25, 2018
SUCCESSFUL SITE VISIT OF GOVERNMENTAL ENVIRONMENTAL AGENCY
* January 1, 2019
COMPLETION OF INTERIOR WALLS SECURITY SYSTEMS
- Anticipated Upcoming Milestones
January 17, 2019
HEMP SEPERATOR TRAINING AND BEGIN PROCESSING OF HEMP
Update On Our Partners
planted first crop
obtained first licence to grow
purchased first 10ha of land
commenced first run of finance
Closed first run of finance
extraction of first crop
dragonfly product online
open loan note
EIS status granted
3yr gmp licence granted
signed ceuta as a distributor
commenced second harvest
cbd content crop analysis 7.58%
first bulk sale order (germany)
season 2 harvest completed
sale to day lewis pharmacy
closed loan note
Boots distribution deal
- Jan 8, 2019 | Canopy Growth
- Dec 14, 2018 | Next Avenue
- Dec 13, 2018 | NBC 15
- Oct 27, 2018 | The New York Times